Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-Term Androgen Priming in IVF
NCT00286364Phase 4Completed
- Sponsor
- Rigshospitalet
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of anastrozole in infertility (2 arms), sponsored by Rigshospitalet. Primary endpoint: Number of top-quality embryos. Status: completed.
02
Drugs
anastrozole
03
Conditions
infertility
Beyond the preview
Go deeper on NCT00286364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00286364.